NCT03728972 2025-10-23Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal TypeMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting19 enrolled 9 charts